At Heveren, we provide an advanced range of cardiovascular products tailored to meet the growing demand for effective cardiac care. From anti-hypertensives to lipid-lowering agents and heart failure management, our cardiology portfolio supports healthcare professionals in ensuring optimal heart health for patients.

Our CARDIOLOGY range

Dyslipidemia is a global public health problem that affects millions of people and increases the risk of cardiovascular disease, the leading cause of death worldwide.

According to a systematic review protocol, the global prevalence of dyslipidemia in adults is estimated to range from 20% to 80%, depending on the definition and criteria used.

Around more than 10 million cases per year reported in India.

The incidence and mortality of dyslipidemia are challenging to measure directly, as dyslipidemia is usually asymptomatic and often coexists with other risk factors, such as hypertension, diabetes, obesity, and smoking.

The prevalence of dyslipidemia in children and adolescents is increasing, especially in developed countries, due to the rising rates of obesity, sedentary lifestyles, and unhealthy diets.

Recent studies have reported that high cholesterol is present in 25–30% of urban and 15–20% rural subjects.

ROSAFIN

Rosuvastatin 10mg, 20mg and 40mg Tablets

view more

ROSAFIN A

Rosuvastatin 10mg and Aspirin 75/150mg Capsules

view more

ROSAFIN GOLD

Rosuvastatin 10mg/20mg and Aspirin 75mg and Clopidogrel 75mg Capsules

view more

ROSAFIN F

Rosuvastatin 10mg and Fenofibrate 160mg Capsules

view more

Hypertension is the leading cause of cardiovascular disease and premature death worldwide.

An estimated 1.28 billion adults aged 30–79 years worldwide have hypertension, most (two-thirds) living in low- and middle-income countries.

An estimated 46% of adults with hypertension are unaware that they have the condition.

Less than half of adults (42%) with hypertension are diagnosed and treated. Approximately 1 in 5 adults (21%) with hypertension have it under control.

Hypertension is a major cause of premature death worldwide.

One of the global targets for noncommunicable diseases is to reduce the prevalence of hypertension by 33% between 2010 and 2030.

TELIPURE

Telmisartan 40 mg Tablets

view more

TELIPURE H

Telmisartan 40mg and Hydrochlorothiazide 12.5mg Tablets

view more

TELIPURE A

Telmisartan 40 mg and Amlodipine Besylate 5mg Tablets

view more

TELIPURE AMH

Telmisartan 40mg and Amlodipine Besylate 5mg and Hydrochlorothiazide 12.5mg Tablets 

view more

TELIPURE LN

Telmisartan 40 mg and Cilnidipine 10mg Tablets

view more

LOBP

Metoprolol 25mg PR and 50mg PR Tablets

view more

LOBP T

Metoprolol 25/50mg and Telmisartan 40 mg Tablets

view more

LOBP R

Metoprolol 50mg SR and Ramipril 5mg Tablets

view more

Critical condition such as Cardiovascular Disease, Anxiety, Psychiatric Disorder, Dementia & Migraine.

Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year.

Anxiety disorders are the world’s most common mental disorders, affecting 301 million people in 2019.

More women are affected by anxiety disorders than men. 1 in every 8 people in the world live with a Psychiatric Disorder.

Most people do not have access to effective care.

GINKOREN D

Ginkgo Biloba 40mg and Vitamin D3 Tablets

view more

Trusted Cardiac Care for Every Heartbeat

From hypertension to cholesterol and heart failure, Heveren’s cardiology solutions are formulated to support heart health and improve outcomes for cardiac patients.

✅ High efficacy in blood pressure & lipid control
✅ Suitable for chronic cardiovascular conditions
✅ Backed by trusted clinical standards

Contact us today for expert guidance or to place an order!